Drugs / Diphtheria and Tetanus toxoids adsorbed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02089347 Comparator | Mar → Sep 2014 | diphtheria, pertussis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria and Tetanus toxoids adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02089347 ↗ |
| Modality | Vaccine | “DT vaccine” NCT02089347 ↗ |
| Route | Subcutaneous | “Subcutaneously” NCT02089347 ↗ |